Binding molecules for bcma and cd3
US-2025346684-A1 · Nov 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Rau Doris patents
Rau Doris is listed as an inventor on 59 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rau Doris |
| Total patents | 59 |
| First publication | Jan 22, 2015 |
| Latest publication | Nov 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody constructs for CDH19 and CD3
US-12441796-B2 · Oct 14, 2025 · US
Antibody constructs for msln and cd3
US-2025282863-A1 · Sep 11, 2025 · US
Heteromultimer binding dll3 and cd3
US-2025282869-A1 · Sep 11, 2025 · US
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
US-2025163179-A1 · May 22, 2025 · US
Binding molecules for BCMA and CD3
US-12281175-B2 · Apr 22, 2025 · US
Binding molecules for BCMA and CD3
US-12281176-B2 · Apr 22, 2025 · US
Cross-species-specific PSMAxCD3 bispecific single chain antibody
US-12281172-B2 · Apr 22, 2025 · US
Bispecific antibody constructs for cdh3 and cd3
US-2025092133-A1 · Mar 20, 2025 · US
Compositions comprising cross-species-specific antibodies and uses thereof
US-2025064927-A1 · Feb 27, 2025 · US
Recent patents
Latest publications not already listed above.
Antibody constructs for msln and cd3
US-2024400673-A1 · Dec 5, 2024 · US
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
US-12152078-B2 · Nov 26, 2024 · US
Cd20 and cd22 targeting antigen-binding molecules for use in proliferative diseases
US-2024384006-A1 · Nov 21, 2024 · US
Multitargeting bispecific antigen-binding molecules of increased selectivity
US-2024209078-A1 · Jun 27, 2024 · US
Cross-species-specific single domain bispecific single chain antibody
US-11987633-B2 · May 21, 2024 · US
Bispecific antibody constructs for CDH3 and CD3
US-11926666-B2 · Mar 12, 2024 · US
Compositions comprising cross-species-specific antibodies and uses thereof
US-11925684-B2 · Mar 12, 2024 · US
Antibody constructs for MSLN and CD3
US-11884720-B2 · Jan 30, 2024 · US
Antibody Constructs for CDH19 and CD3
US-2024010724-A1 · Jan 11, 2024 · US
Polypeptide constructs binding to cd3
US-2023406929-A1 · Dec 21, 2023 · US
Cross-species-specific binding domain
US-2023357444-A1 · Nov 9, 2023 · US
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
US-2023037742-A1 · Feb 9, 2023 · US
Bispecific antibody constructs for cdh3 and cd3
US-2023041876-A1 · Feb 9, 2023 · US
Antibody constructs for CDH19 and CD3
US-11498964-B2 · Nov 15, 2022 · US
Binding molecules for bcma and cd3
US-2022356268-A1 · Nov 10, 2022 · US
Cross-species-specific PSMAxCD3 bispecific single chain antibody
US-11472886-B2 · Oct 18, 2022 · US
Binding molecules for bcma and cd3
US-2022251243-A1 · Aug 11, 2022 · US
Method for treating glioblastoma or glioma with anitbody constructs egfrviii and cd3
US-2022064308-A1 · Mar 3, 2022 · US
Binding molecules for bcma and cd3
US-2022064336-A1 · Mar 3, 2022 · US
Cross-species-specific single domain bispecific single chain antibody
US-2022041736-A1 · Feb 10, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Res Munich Gmbh | 57 |
| Amgen Inc | 23 |
| Boehringer Ingelheim Int | 7 |
| Kufer Peter | 2 |
| Lutterbuese Ralf | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 59 |
| A61P35/00 | 54 |
| C07K16/2809 | 48 |
| C07K2317/622 | 45 |
| A61K2039/505 | 40 |